Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 4

Roller Coaster 3

Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure- Response Analyses Underutilized?

Wednesday, November 13, 2024
11:50 AM – 12:05 PM MST
Location: Sonoran Sky Ballroom 5 - 8

    Speaker(s)

  • Ahmed H. Salem, PhD, FCP

    Senior Research Fellow
    Abbvie

    Disclosure(s): Abbvie: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):
Ahmed H. Salem, PhD, FCP: Abbvie: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Back to Top